On January 18th, 2023, the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security issued a notice on the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2022), and our company's product Shugammadex geng Glucose Sodium Injection was included in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2022). The new medical insurance drug list was officially implemented on March 1, 2023.
On January 18th, 2023, the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security issued a notice on the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2022), and our company's product Shugammadex geng Glucose Sodium Injection was included in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2022). The new medical insurance drug list was officially implemented on March 1, 2023.
